Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081377 | SCV000113308 | benign | not specified | 2013-06-12 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000081377 | SCV000297207 | benign | not specified | 2015-11-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081377 | SCV000518814 | benign | not specified | 2016-02-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Center for Pediatric Genomic Medicine, |
RCV000514539 | SCV000610555 | likely benign | not provided | 2017-03-17 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001083411 | SCV000641216 | benign | MOGS-congenital disorder of glycosylation | 2024-01-30 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001083411 | SCV001473065 | benign | MOGS-congenital disorder of glycosylation | 2022-09-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001083411 | SCV002805408 | likely benign | MOGS-congenital disorder of glycosylation | 2021-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000514539 | SCV004155074 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | MOGS: BP4, BS2 |